Obstacles to the Early Diagnosis and Management of Patent Ductus Arteriosus

References

• Carrillo SA. “What we know is little, and what we are ignorant of is immense”. J Thorac Cardiovasc Surg. 2017;154(6):2052–2053. doi:10.1016/j.jtcvs.2017.08.111
   PubMed Web of Science ®Google Scholar
• Siegel RE. Galen’s experiments and observations on pulmonary blood flow and respiration. Am J Cardiol. 1962;10(5):738–745. doi:10.1016/0002-9149(62)90250-3
   PubMed Web of Science ®Google Scholar
• Hundscheid T, van den Broek M, van der Lee R, de Boode WP. Understanding the pathobiology in patent ductus arteriosus in prematurity-beyond prostaglandins and oxygen. Pediatr Res. 2019;86(1):28–38. doi:10.1038/s41390-019-0387-7
   PubMed Web of Science ®Google Scholar
• Reese J. Towards a greater understanding of the ductus arteriosus. Semin Perinatol. 2018;42(4):199–202. doi:10.1053/j.semperi.2018.05.001
   PubMed Web of Science ®Google Scholar
• Hamrick SEG, Sallmon H, Rose AT, et al. Patent Ductus Arteriosus of the Preterm Infant. Pediatrics. 2020;146(5). doi:10.1542/peds.2020-1209
   PubMed Web of Science ®Google Scholar
• Singh Y, Katheria A, Tissot C. Functional Echocardiography in the Neonatal Intensive Care Unit. Indian Pediatr. 2018;55(5):417–424. doi:10.1007/s13312-018-1286-4
   PubMed Web of Science ®Google Scholar
• Singh Y, Gupta S, Groves AM, et al. Expert consensus statement ‘Neonatologist-performed Echocardiography (NoPE)’-training and accreditation in UK. Eur J Pediatr. 2016;175(2):281–287. doi:10.1007/s00431-015-2633-2
   PubMed Web of Science ®Google Scholar
• Paudel G, Joshi V. Echocardiography of the patent ductus arteriosus in premature infant. Congenit Heart Dis. 2019;14(1):42–45. doi:10.1111/chd.12703
   PubMed Web of Science ®Google Scholar
• Vaisbourd Y, Sharif D, Riskin A, et al. The effect of patent ductus arteriosus on coronary artery blood flow in premature infants: a prospective observational pilot study. J Perinatol. 2020;40(9):1366–1374. doi:10.1038/s41372-020-0622-4
   PubMed Web of Science ®Google Scholar
• Noori S, Seri I. Hemodynamic antecedents of peri/intraventricular hemorrhage in very preterm neonates. Semin Fetal Neonatal Med. 2015;20(4):232–237. doi:10.1016/j.siny.2015.02.004
   PubMed Web of Science ®Google Scholar
• Lemmers PM, Benders MJ, D’Ascenzo R, et al. Patent Ductus Arteriosus and Brain Volume. Pediatrics. 2016;137(4). doi:10.1542/peds.2015-3090
   Web of Science ®Google Scholar
• Dollberg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr. 2005;40(2):184–188. doi:10.1097/00005176-200502000-00019
   PubMed Web of Science ®Google Scholar
• Homedi A, De La Hoz A, Miller MR, Lalitha R, McClean M, Bhattacharya S. Impact of Targeted Neonatal Echocardiography on Patent Ductus Arteriosus Management in a Canadian Tertiary Care Neonatal Unit: a Retrospective Cohort Study. Am J Perinatol. 2023. doi:10.1055/s-0043-1774313
   PubMed Web of Science ®Google Scholar
• Rios DR, Bhattacharya S, Levy PT, McNamara PJ. Circulatory Insufficiency and Hypotension Related to the Ductus Arteriosus in Neonates. Front Pediatr. 2018;6:62. doi:10.3389/fped.2018.00062
   PubMed Web of Science ®Google Scholar
• Willis KA, Weems MF. Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia. Congenit Heart Dis. 2019;14(1):27–32. doi:10.1111/chd.12691
   PubMed Web of Science ®Google Scholar
• Kappico JM, Cayabyab R, Ebrahimi M, et al. Pulmonary hemorrhage in extremely low birth weight infants: significance of the size of left to right shunting through a valve incompetent patent foramen ovale. J Perinatol. 2022;42(9):1233–1237. doi:10.1038/s41372-022-01464-9
   PubMed Web of Science ®Google Scholar
• Scholl JE, Yanowitz TD. Pulmonary hemorrhage in very low birth weight infants: a case-control analysis. J Pediatr. 2015;166(4):1083–1084. doi:10.1016/j.jpeds.2014.12.032
   PubMed Web of Science ®Google Scholar
• Bussmann N, Smith A, Breatnach CR, et al. Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort. J Perinatol. 2021;41(5):1134–1141. doi:10.1038/s41372-021-01002-z
   PubMed Web of Science ®Google Scholar
• Philip R, Waller BR, Chilakala S, et al. Hemodynamic and clinical consequences of early versus delayed closure of patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2021;41(1):100–108. doi:10.1038/s41372-020-00772-2
   PubMed Web of Science ®Google Scholar
• Clyman RI, Kaempf J, Liebowitz M, et al. Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: a Secondary Analysis of the PDA-TOLERATE trial. J Pediatr. 2021;229:283–288 e282. doi:10.1016/j.jpeds.2020.09.047
   PubMed Web of Science ®Google Scholar
• Noori S, McCoy M, Friedlich P, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123(1):e138–144. doi:10.1542/peds.2008-2418
   PubMed Web of Science ®Google Scholar
• Sathanandam S, Whiting S, Cunningham J, et al. Practice variation in the management of patent ductus arteriosus in extremely low birth weight infants in the United States: survey results among cardiologists and neonatologists. Congenit Heart Dis. 2019;14(1):6–14. doi:10.1111/chd.12729
   PubMed Web of Science ®Google Scholar
• Hundscheid T, El-Khuffash A, McNamara PJ, de Boode WP. Survey highlighting the lack of consensus on diagnosis and treatment of patent ductus arteriosus in prematurity. Eur J Pediatr. 2022;181(6):2459–2468. doi:10.1007/s00431-022-04441-8
   PubMed Web of Science ®Google Scholar
• Benitz WE, Bhombal S. The use of non-steroidal anti-inflammatory drugs for patent ductus arteriosus closure in preterm infants. Semin Fetal Neonatal Med. 2017;22(5):302–307. doi:10.1016/j.siny.2017.07.004
   PubMed Web of Science ®Google Scholar
• Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010;30(4):241–252. doi:10.1038/jp.2010.3
   PubMed Web of Science ®Google Scholar
• Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units. J Pediatr. 2017;189:105–112. doi:10.1016/j.jpeds.2017.05.024
   PubMed Web of Science ®Google Scholar
• Gross RE. Surgical Management of the Patent Ductus Arteriosus: with Summary of Four Surgically Treated Cases. Ann Surg. 1939;110(3):321–356. doi:10.1097/00000658-193909000-00001
   PubMedGoogle Scholar
• Reese J, Scott TA, Patrick SW. Changing patterns of patent ductus arteriosus surgical ligation in the United States. Semin Perinatol. 2018;42(4):253–261. doi:10.1053/j.semperi.2018.05.008
   PubMed Web of Science ®Google Scholar
• Kabra NS, Schmidt B, Roberts RS, et al. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007;150(3):229–234, 234 e221. doi:10.1016/j.jpeds.2006.11.039
   PubMed Web of Science ®Google Scholar
• Weisz DE, Mirea L, Rosenberg E, et al. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants. JAMA Pediatr. 2017;171(5):443–449. doi:10.1001/jamapediatrics.2016.5143
   PubMed Web of Science ®Google Scholar
• Serrano RM, Madison M, Lorant D, Hoyer M, Alexy R. Comparison of ‘post-patent ductus arteriosus ligation syndrome’ in premature infants after surgical ligation vs. percutaneous closure. J Perinatol. 2020;40(2):324–329. doi:10.1038/s41372-019-0513-8
   PubMed Web of Science ®Google Scholar
• El-Khuffash AF, Jain A, Weisz D, Mertens L, McNamara PJ. Assessment and treatment of post patent ductus arteriosus ligation syndrome. J Pediatr. 2014;165(1):46–52 e41. doi:10.1016/j.jpeds.2014.03.048
   PubMed Web of Science ®Google Scholar
• Benjamin JR, Smith PB, Cotten CM, Jaggers J, Goldstein RF, Malcolm WF. Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants. J Perinatol. 2010;30(6):408–413. doi:10.1038/jp.2009.124
   PubMed Web of Science ®Google Scholar
• Ashfaq A, Rettig RL, Chong A, Sydorak R. Outcomes of patent ductus arteriosus ligation in very low birth weight premature infants: a retrospective cohort analysis. J Pediatr Surg. 2022;57(7):1201–1204. doi:10.1016/j.jpedsurg.2022.02.037
   PubMed Web of Science ®Google Scholar
• Ishida S, Yamaguchi A, Ooka M, Kenmochi M, Nakanishi H. Evaluation of postoperative complications for patent ductus arteriosus in extremely-low-birthweight infants. Pediatr Int. 2022;64(1):e14759. doi:10.1111/ped.14759
   PubMed Web of Science ®Google Scholar
• Sathanandam S, Balduf K, Chilakala S, et al. Role of Transcatheter patent ductus arteriosus closure in extremely low birth weight infants. Catheter Cardiovasc Interv. 2019;93(1):89–96. doi:10.1002/ccd.27808
   PubMed Web of Science ®Google Scholar
• Rodriguez Ogando A, Planelles Asensio I, de la Blanca ARS, et al. Surgical Ligation Versus Percutaneous Closure of Patent Ductus Arteriosus in Very Low-Weight Preterm Infants: which are the Real Benefits of the Percutaneous Approach? Pediatr Cardiol. 2018;39(2):398–410. doi:10.1007/s00246-017-1768-5
   PubMed Web of Science ®Google Scholar
• Bischoff AR, Kennedy KF, Backes CH, Sathanandam S, McNamara PJ. Percutaneous Closure of the Patent Ductus Arteriosus in Infants </=2 kg: IMPACT Registry insights. Pediatrics. 2023.
   PubMedGoogle Scholar
• Bischoff AR, Jasani B, Sathanandam SK, Backes C, Weisz DE, McNamara PJ. Percutaneous Closure of Patent Ductus Arteriosus in Infants 1.5 kg or Less: a Meta-Analysis. J Pediatr. 2021;230:84–92 e14. doi:10.1016/j.jpeds.2020.10.035
   PubMed Web of Science ®Google Scholar
• PubMed, National Library of Medicine. Search term: “patent ductus arteriosus”. Filters: clinical Trial + 1976-2023. https://pubmed.ncbi.nlm.nih.gov/?term=patent%20ductus%20arteriosus&filter=pubt.clinicaltrial&filter=years.1976-2023. Accessed January 29, 2024.
   Google Scholar
• Gupta S, Subhedar NV, Bell JL, et al. Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen. N Engl J Med. 2024;390(4):314–325. doi:10.1056/NEJMoa2305582
   PubMedGoogle Scholar
• Hundscheid T, Onland W, Kooi EMW, et al. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. N Engl J Med. 2023;388(11):980–990. doi:10.1056/NEJMoa2207418
   PubMed Web of Science ®Google Scholar
• El-Khuffash A, James AT, Corcoran JD, et al. A Patent Ductus Arteriosus Severity Score Predicts Chronic Lung Disease or Death before Discharge. J Pediatr. 2015;167(6):1354–1361 e1352. doi:10.1016/j.jpeds.2015.09.028
   PubMed Web of Science ®Google Scholar
• Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99–F104. doi:10.1136/archdischild-2013-304695
   PubMed Web of Science ®Google Scholar
• Sosenko IR, Fajardo MF, Claure N, Bancalari E. Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr. 2012;160(6):929–935 e921. doi:10.1016/j.jpeds.2011.12.031
   PubMed Web of Science ®Google Scholar
• Smith A, Mullaly R, Franklin O, El-Khuffash A. Reproducibility of the EL-Khuffash PDA severity score and PDA diameter measurements in extremely preterm infants. Early Hum Dev. 2023;184:105832. doi:10.1016/j.earlhumdev.2023.105832
   PubMed Web of Science ®Google Scholar
• Hundscheid T, Onland W, van Overmeire B, et al. Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial). BMC Pediatr. 2018;18(1):262. doi:10.1186/s12887-018-1215-7
   PubMed Web of Science ®Google Scholar
• Semberova J, Sirc J, Miletin J, et al. Spontaneous Closure of Patent Ductus Arteriosus in Infants </=1500 g. Pediatrics. 2017;140(2). doi:10.1542/peds.2016-4258
   PubMed Web of Science ®Google Scholar
• Clyman RI, Liebowitz M, Kaempf J, et al. PDA-TOLERATE Trial: an Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age. J Pediatr. 2019;205:41–48 e46. doi:10.1016/j.jpeds.2018.09.012
   PubMed Web of Science ®Google Scholar
• Liebowitz M, Katheria A, Sauberan J, et al. Lack of Equipoise in the PDA-TOLERATE Trial: a Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial. J Pediatr. 2019;213:222–226 e222. doi:10.1016/j.jpeds.2019.05.049
   PubMed Web of Science ®Google Scholar
• El-Khuffash A, Bussmann N, Breatnach CR, et al. A Pilot Randomized Controlled Trial of Early Targeted Patent Ductus Arteriosus Treatment Using a Risk Based Severity Score (The PDA RCT). J Pediatr. 2021;229:127–133. doi:10.1016/j.jpeds.2020.10.024
   PubMed Web of Science ®Google Scholar
• Davidson JM, Ferguson J, Ivey E, Philip R, Weems MF, Talati AJ. A randomized trial of intravenous Acetaminophen versus indomethacin for treatment of hemodynamically significant PDAs in VLBW infants. J Perinatol. 2021;41(1):93–99. doi:10.1038/s41372-020-0694-1
   PubMed Web of Science ®Google Scholar
• Bokiniec R, Wlasienko P, Borszewska-Kornacka MK, Madajczak D, Szymkiewicz-Dangel J. Myocardial performance index (Tei index) in term and preterm neonates during the neonatal period. Kardiol Pol. 2016;74(9):1002–1009. doi:10.5603/KP.a2016.0056
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Harada K, Ishida A, Tamura M, Takada G. Left ventricular preload reserve in preterm infants with patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 1994;71(2):F118–121. doi:10.1136/fn.71.2.F118
   PubMed Web of Science ®Google Scholar
• Su BH, Lin HY, Huang FK, Tsai ML, Huang YT. Circulatory Management Focusing on Preventing Intraventricular Hemorrhage and Pulmonary Hemorrhage in Preterm Infants. Pediatr Neonatol. 2016;57(6):453–462. doi:10.1016/j.pedneo.2016.01.001
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lou X, Hua L, Jia X, Xu L, Zhao M. Cardiopulmonary Ultrasound-Guided Treatment of Premature Infants with Respiratory Failure and Patent Ductus Arteriosus: a Randomized, Controlled Trial. Indian J Pediatr. 2023;90(11):1103–1109. doi:10.1007/s12098-023-04489-w
   PubMed Web of Science ®Google Scholar
• Relangi D, Somashekar S, Jain D, et al. Changes in Patent Ductus Arteriosus Treatment Strategy and Respiratory Outcomes in Premature Infants. J Pediatr. 2021;235:58–62. doi:10.1016/j.jpeds.2021.04.030
   PubMed Web of Science ®Google Scholar
• Altit G, Saeed S, Beltempo M, Claveau M, Lapointe A, Basso O. Outcomes of Extremely Premature Infants Comparing Patent Ductus Arteriosus Management Approaches. J Pediatr. 2021;235:49–57 e42. doi:10.1016/j.jpeds.2021.04.014
   PubMed Web of Science ®Google Scholar
• Weisz DE, McNamara PJ. Patent ductus arteriosus ligation and adverse outcomes: causality or bias? J Clin Neonatol. 2014;3(2):67–75. doi:10.4103/2249-4847.134670
   PubMedGoogle Scholar
• Backes CH, Cheatham SL, Deyo GM, et al. Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: feasibility and Complications. J Am Heart Assoc. 2016;5(2). doi:10.1161/JAHA.115.002923
   PubMed Web of Science ®Google Scholar
• Mirea L, Sankaran K, Seshia M, et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr. 2012;161(4):689–694 e681. doi:10.1016/j.jpeds.2012.05.007
   PubMed Web of Science ®Google Scholar
• Weisz DE, More K, McNamara PJ, Shah PS. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133(4):e1024–1046. doi:10.1542/peds.2013-3431
   PubMed Web of Science ®Google Scholar
• Benitz WE. Patent ductus arteriosus: to treat or not to treat? Arch Dis Child Fetal Neonatal Ed. 2012;97(2):F80–82. doi:10.1136/archdischild-2011-300381
   PubMed Web of Science ®Google Scholar
• Sallmon H, Koehne P, Hansmann G. Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus. Clin Perinatol. 2016;43(1):113–129. doi:10.1016/j.clp.2015.11.008
   PubMed Web of Science ®Google Scholar
• Isayama T, Kusuda S, Reichman B, et al. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm. J Pediatr. 2020;220:34–39 e35. doi:10.1016/j.jpeds.2020.01.069
   PubMed Web of Science ®Google Scholar
• Philip R, Waller BR, Agrawal V, et al. Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device. Catheter Cardiovasc Interv. 2016;87(2):310–317. doi:10.1002/ccd.26287
   PubMed Web of Science ®Google Scholar
• Paudel G, Johnson JN, Philip R, et al. Echocardiographic versus Angiographic Measurement of the Patent Ductus Arteriosus in Extremely Low Birth Weight Infants and the Utility of Echo Guidance for Transcatheter Closure. J Am Soc Echocardiogr. 2021;34(10):1086–1094. doi:10.1016/j.echo.2021.06.005
   PubMed Web of Science ®Google Scholar
• Abushaban L, Vel MT, Rathinasamy J, Sharma PN. Normal reference ranges for left ventricular dimensions in preterm infants. Ann Pediatr Cardiol. 2014;7(3):180–186. doi:10.4103/0974-2069.140832
   PubMedGoogle Scholar
• El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed. 2005;90(5):F419–422. doi:10.1136/adc.2003.027698
   PubMed Web of Science ®Google Scholar
• Broadhouse KM, Price AN, Durighel G, et al. Assessment of PDA shunt and systemic blood flow in newborns using cardiac MRI. NMR Biomed. 2013;26(9):1135–1141. doi:10.1002/nbm.2927
   PubMed Web of Science ®Google Scholar
• Smith A, El-Khuffash AF. Defining “Haemodynamic Significance” of the Patent Ductus Arteriosus: do We Have All the Answers? Neonatology. 2020;117(2):225–232. doi:10.1159/000506988
   PubMed Web of Science ®Google Scholar
• Clyman RI, Hills NK, Cambonie G, et al. Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia. Pediatr Res. 2022;91(3):652–658. doi:10.1038/s41390-021-01475-w
   PubMed Web of Science ®Google Scholar
• Roze JC, Cambonie G, Marchand-Martin L, et al. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants. JAMA. 2015;313(24):2441–2448. doi:10.1001/jama.2015.6734
   PubMed Web of Science ®Google Scholar
• Giesinger RE, Hobson AA, Bischoff AR, Klein JM, McNamara PJ. Impact of early screening echocardiography and targeted PDA treatment on neonatal outcomes in “22-23” week and “24-26” infants. Semin Perinatol. 2023;47(2):151721. doi:10.1016/j.semperi.2023.151721
   PubMed Web of Science ®Google Scholar